These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16775894)

  • 1. Percutaneous coronary intervention under the rigid restriction of contrast media dose in patients with chronic renal insufficiency.
    Yamamoto E; Takano H; Takayama M
    J Invasive Cardiol; 2006 Jun; 18(6):E169-72. PubMed ID: 16775894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel technique for ultra-low contrast administration during angiography or intervention.
    Nayak KR; Mehta HS; Price MJ; Russo RJ; Stinis CT; Moses JW; Mehran R; Leon MB; Kandzari DE; Teirstein PS
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1076-83. PubMed ID: 20146209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal outcome of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Nomura S; Taki F; Tamagaki K; Futatsuyama M; Nishihara S; Anzai H; Nishi Y; Takao N; Hayashida N; Komatsu Y
    Int J Cardiol; 2011 Jan; 146(2):295-6. PubMed ID: 21095626
    [No Abstract]   [Full Text] [Related]  

  • 4. Optical coherence tomography-guided percutaneous coronary intervention in a patient with chronic kidney disease using zero contrast administration.
    Rivero F; Antuña P; Cuesta J; García-Guimaraes M; Bastante T; Alfonso F
    Coron Artery Dis; 2019 Mar; 30(2):156-157. PubMed ID: 30531255
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultra-Low Contrast Volume for Patients with Advanced Chronic Kidney Disease Undergoing Coronary Procedures.
    Rozenbaum Z; Benchetrit S; Rozenbaum E; Neumark E; Mosseri M; Pereg D
    Nephron; 2018; 138(4):296-302. PubMed ID: 29393219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.
    Karimi Galougahi K; Mintz GS; Karmpaliotis D; Ali ZA
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):E85-E89. PubMed ID: 28303645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in Contrast Nephropathy From Coronary Angiography and Percutaneous Coronary Intervention With Ultra-Low Contrast Delivery Using an Automated Contrast Injector System.
    Kelly SC; Li S; Stys TP; Thompson PA; Stys AT
    J Invasive Cardiol; 2016 Nov; 28(11):446-450. PubMed ID: 27430665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship between hyperuricemia and contrast-induced nephropathy in patients with chronic kidney disease undergoing percutaneous coronary intervention].
    Liu YH; Tan N; Liu Y; Ye P; He YT; Ran P; Jiang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Sep; 41(9):740-3. PubMed ID: 24331800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and contrast-induced acute kidney injury with coronary angiography.
    Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
    Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telescoping catheter technique: looking towards the kidneys.
    Mamas MA; Fath-Ordoubadi F; Fraser DG
    Cardiovasc Revasc Med; 2011; 12(2):123-8. PubMed ID: 21421191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-based percutaneous coronary intervention in a patient with renal insufficiency.
    Bokhari SW; Wen YH; Winters RJ
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):358-61. PubMed ID: 12594702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel use of the GuideLiner catheter to minimize contrast use during PCI in a patient with chronic kidney disease.
    Tunuguntla A; Daneault B; Kirtane AJ
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):453-5. PubMed ID: 22110014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.
    Subedi B; Siddique MA; Zaman SM; Hasan MI; Arzu J; Awal A; Fatema K
    Mymensingh Med J; 2011 Apr; 20(2):270-4. PubMed ID: 21522099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
    Nawa T; Nishigaki K; Kinomura Y; Tanaka T; Yamada Y; Kawasaki M; Minatoguchi S
    Int J Cardiol; 2015 Sep; 195():228-34. PubMed ID: 26048382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
    Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
    Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast volume use in manual vs automated contrast injection systems for diagnostic coronary angiography and percutaneous coronary interventions.
    Hwang JR; D'Alfonso S; Kostuk WJ; Diamantouros P; Teefy P; Jablonsky G; Lavi S
    Can J Cardiol; 2013 Mar; 29(3):372-6. PubMed ID: 23352426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
    Toso A; Maioli M; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Manzone C; Amato M; Bellandi F
    Am J Cardiol; 2010 Feb; 105(3):288-92. PubMed ID: 20102936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
    Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial.
    Dvoršak B; Kanič V; Ekart R; Bevc S; Hojs R
    Ther Apher Dial; 2013 Aug; 17(4):384-90. PubMed ID: 23931876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.